BKEMV
Active substance: eculizumab
INJECTION, SOLUTION, CONCENTRATE · ECULIZUMAB 300 mg/30mL
United StatesActive
Marketing holder: Amgen Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- ECULIZUMAB · 300 mg/30mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 9 |
|
| EU 3 |
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-33ec-738c-a765-dd7c0c8e03e9,01a120c3-4f8e-7f1b-adef-ac8565364e2f,01a120c3-691f-7b00-bd72-348ead99ea2d,01a120c3-cf46-77eb-b83b-fa89bb921515,01a120c3-daf6-70ff-bdf0-3952728ad64e;count=8 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12093-c3bf-7693-a915-0a7ffa7898c8,01a12096-2195-71e2-bfc9-83c3418f9649,01a1209d-0b64-72b6-b4a5-b0833e5e34f7;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55513-180
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 55513-180 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55513-180 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55513-180 · Verified 2026-10-09 · open in source